ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO0640

Determining the Role of GPR161 in PKD

Session Information

Category: Genetic Diseases of the Kidneys

  • 1201 Genetic Diseases of the Kidneys: Monogenic Kidney Diseases

Authors

  • Gao, Yue, Mayo Clinic Minnesota, Rochester, Minnesota, United States
  • Chen, Chuan, Mayo Clinic Minnesota, Rochester, Minnesota, United States
  • Hu, Jinghua, Mayo Clinic Minnesota, Rochester, Minnesota, United States
  • Harris, Peter C., Mayo Clinic Minnesota, Rochester, Minnesota, United States
  • Ling, Kun, Mayo Clinic Minnesota, Rochester, Minnesota, United States
Background

Autosomal dominant polycystic kidney disease (ADPKD) is the most common form of life-threatening monogenic kidney disease. Abnormal cAMP increase in renal epithelial cells are correlated with the formation of kidney cysts. Recent evidence suggested a notion that the compartmentalized cAMP elevation in primary cilia triggers renal cystogenesis. Yet, how the ciliary cAMP is regulated remains vague. The cystic kidney phenotype is observed in INPP5E-null mice. Loss of INPP5E increases the TULP3-dependent ciliary trafficking of GPR161. It was shown recently that GPR161 undergoes a constitutive self-activation, raising a possibility that GPR161 may contribute to the cAMP elevation in INPP5E-null cilia that may underlie the renal cystogenesis in INPP5E-null kidneys.

Methods

We constructed a ciliary cAMP indicator by fusing NPHP3 (aa 1-203) to the cAMP indicator Pink Flamindo (cPF). The stable expression of cPF was introduced in the IMCD3Flp-In cell line. We utilized CRISPR/Cas9 to knockout Inpp5e, Gpr161, or both. The self-activation deficient GPR161 mutants are made using site-directed mutagenesis and re-expressed back into Gpr161-null cells. 3D-Matrigel culture is employed for in vitro cystogenesis of IMCD3 cells. Inpp5ef/f, Gpr161f/f, and double conditional knockout mice are generated.

Results

GPR161 and cAMP activity in cilia are both strongly increased in Inpp5e-null IMCD3 cells. Loss of GPR161 suppresses both the basal level and increase of ciliary cAMP in parental and Inpp5e-null IMCD3 cells, respectively. Notably, re-expression of the wild-type GPR161 back in Gpr161-null IMCD3 cells completely recues the cPF intensity in cilia. On the other hand, Inpp5e-null IMCD3 cells develop cystogenesis in 3D-Matrigel. Interestingly, the enlargement of Inpp5e-null IMCD3 cysts is insensitive to forskolin treatment and can be suppressed by co-depletion of GPR161. Studies on testing whether non-self-activatable variants of GPR161 can rescue the ciliary cAMP and cystogenesis in Inpp5e/Gpr161 dko IMCD3 cells are ongoing, as well as the animal studies.

Conclusion

Our current results suggest an intriguing possibility that GPR161 via self-activation constitutively produces the basal level of cAMP in primary cilia, which may elevate the ciliary cAMP to a level that triggers cystogenesis when PKD mutations cause abnormal increase of GPR161 or weaken certain counteracting mechanisms in cilia.

Digital Object Identifier (DOI)